Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05854485 · ClinicalTrials.gov registry record · NA

Robot-Aided Assessment and Rehabilitation of Upper Extremity Function After Stroke

A NA study of Stroke, sponsored by University of Maryland, Baltimore.

Completed
Registry status
NA
Development phase
24
Enrollment target
1
Study location

NCT05854485: Completed NA study of Stroke, sponsored by University of Maryland, Baltimore.

NCT05854485 is a NA study of Stroke that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 24 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05854485, a NA study of Stroke, has completed, sponsored by University of Maryland, Baltimore.

COMPLETED
Registry status
NA
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

The purpose of this clinical trial is to investigate the efficacy of a hybrid-based rehabilitation program for the upper extremity(UE) combining the interventions- Functional Electrical Stimulation (FES) and Robotic rehabilitation in individuals with chronic stroke. The main question it aims to answer is if the Hybrid multi-muscle FES+Robot upper extremity rehabilitation is more effective in improving the upper extremity motor impairments and function as compared to robotic upper extremity training alone.

Primary Outcome

This measure will be collected as the participants performs target reaching out and in movements of the arm. Smoothness will be collected from the REACH robotic device to determine the kinematic changes in the reaching movements. Kinereach/trakStar system will also be utilized to conduct kinematic assessment and determine the translation of training effects into functional upper extremity use.

Conditions Studied

Interventions

  • COMBINATION_PRODUCT REACH robotic training and multi-muscle Functional Electrical Stimulation (FES) group
  • COMBINATION_PRODUCT Robot only group

Study Locations (1)

Maryland

  • University of Maryland School of Medicine - Baltimore

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2023-09-06
Est. Completion 2025-06-30
Phase NA
University of Maryland, Baltimore

560 total trials

What the finished NCT05854485 record still lists

NCT05854485 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower).

The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 2 interventions - of which REACH robotic training and multi-muscle Functional Electrical Stimulation (FES) group is the first listed.

NCT05854485 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT05854485 about?

NCT05854485 is a clinical study titled "Robot-Aided Assessment and Rehabilitation of Upper Extremity Function After Stroke". The purpose of this clinical trial is to investigate the efficacy of a hybrid-based rehabilitation program for the upper extremity(UE) combining the interventions- Functional Electrical Stimulation (FES) and Robotic rehabilitation in individuals with chronic stroke. The main question it aims to answ...

What is the current status of trial NCT05854485?

This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2023-09-06. Estimated completion is 2025-06-30.

What conditions does trial NCT05854485 study?

This clinical trial studies the following conditions: Stroke.

What interventions are being tested in trial NCT05854485?

The interventions under investigation include: REACH robotic training and multi-muscle Functional Electrical Stimulation (FES) group (COMBINATION_PRODUCT), Robot only group (COMBINATION_PRODUCT).

Who is sponsoring clinical trial NCT05854485?

This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05854485 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05854485's enrollment target sits among peer trials

24 336th of 454 higher than 109 of 454 other Stroke trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02331979 · 24 participants · NA

    Improving Bladder Function in SCI by Neuromodulation

  • NCT03096197 · 24 participants · NA

    Exoskeleton and Spinal Cord Stimulation for SCI

  • NCT03223922 · 24 participants · NA

    Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases

  • NCT03326921 · 24 participants · Phase 1

    HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05854485, the US trial registry maintained by the National Library of Medicine. NCT05854485 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.